Four patients with cutaneous metastases from medullary thyroid cancer

Thyroid

Volumn 18, Issue 8, 2008, Pages 901-905

  Santarpia, Libero ^a   El Naggar, Adel K ^a   Sherman, Steven I ^a   Hymes, Sharon R ^b   Gagel, Robert F ^a   Shaw, Stephanie ^a   Sarlis, Nicholas J ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Texas Health Science Center at Houston   (United States)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; SKIN METASTASIS; THYROID MEDULLARY CARCINOMA; TUMOR BIOPSY;

AGED; CARCINOMA, MEDULLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SKIN NEOPLASMS; THYROID NEOPLASMS;

EID: 50649125131     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0179     Document Type: Article

References (15)

1. Ball DW, Baylin SB, De Butros AC 2000 Medullary thyroid carcinoma. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. 8th ed. Lippincott Williams and Wilkins, Philadelphia, PA, pp 930-943.
2. Kebebew E, Clark OH 2000 Medullary thyroid cancer. Curr Treat Options Oncol 1:359-367.
3. Gagel RF, Marx SJ 2002 Multiple endocrine neoplasia. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky PS, Wilson JD, Foster DW (eds) Williams Textbook of Endocrinology. 10th ed. Saunders, Philadelphia, PA, pp 1717-1762.
4. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070-2075.
5. Orgiana G, Pinna G, Camedda A, De Falco V, Santoro M, Melillo RM, Elisei R, Romei C, Lai S, Carcassi C, Mariotti S 2004 A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure. J Clin Endocrinol Metab 89:4810-4816.
6. Quayle FJ, Moley JF 2005 Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes. J Surg Oncol 89:122-129.
7. Peixoto Callejo I, Americo Brito J, Zagalo CM, Rosa Santos J 2006 Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival. Clin Transl Oncol 8:435-443.
8. Koller EA, Tourtelot JB, Pak HS, Cobb MW, Moad JC, Flynn EA 1998 Papillary and follicular thyroid carcinoma metastatic to the skin: a case report and review of the literature. Thyroid 8:1045-1050.
9. Dahl PR, Brodland DG, Goellner JR, Hay ID 1997 Thyroid carcinoma metastatic to the skin: a cutaneous manifestation of a widely disseminated malignancy. J Am Acad Dermatol 36:531-537.
10. Ibanez ML, Russell WO, Albores-Saavedra J, Lampertico P, White EC, Clark RL 1966 Thyroid carcinoma - biologic behavior and mortality. Postmortem findings in 42 cases, including 27 in which the disease was fatal. Cancer 19:1039-1052.
11. Bevilacqua G, Mariotti S, Castagna M, Marcocci C, Di Coscio GC, Martino E 1984 Cutaneous metastasis of a radiation-associated thyroid medullary carcinoma. J Endocrinol Invest 7:653-657.
12. Ordonez NG, Samaan NA 1987 Medullary carcinoma of the thyroid metastatic to the skin: report of two cases. J Cutan Pathol 14:251-254.
13. Jee MS, Chung YI, Lee MW, Choi JH, Moon KC, Koh JK 2003 Cutaneous metastasis from medullary carcinoma of thyroid gland. Clin Exp Dermatol 28:670-671.
14. Alwaheeb S, Ghazarian D, Boerner SL, Asa SL 2004 Cutaneous manifestations of thyroid cancer: a report of four cases and review of the literature. J Clin Pathol 57:435-438.
15. Uribe M, Fenoglio-Preiser CM, Grimes M, Feind C 1985 Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. Am J Surg Pathol 9:577-594.